Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine plus oral midazolam for CT sedation in children with autism
ChiCTR-TRC-14004761Phase 4Completed
- Sponsor
- Guangzhou Women and Children's Medical Centre
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Autism Spectrum Disorder (ASD) comparing Dexmedetomidine + midazolam with Dexmedetomidine + placebo (2 arms). Primary endpoints: Satisfactory sedation rate, Onset time and 2 more. Started Jun 2014; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ChiCTR-TRC-14004761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004761.